193 related articles for article (PubMed ID: 38300524)
1. Ceramides are fuel gauges on the drive to cardiometabolic disease.
Wilkerson JL; Tatum SM; Holland WL; Summers SA
Physiol Rev; 2024 Jul; 104(3):1061-1119. PubMed ID: 38300524
[TBL] [Abstract][Full Text] [Related]
2. Ceramides - Lipotoxic Inducers of Metabolic Disorders.
Chaurasia B; Summers SA
Trends Endocrinol Metab; 2015 Oct; 26(10):538-550. PubMed ID: 26412155
[TBL] [Abstract][Full Text] [Related]
3. You aren't IMMUNE to the ceramides that accumulate in cardiometabolic disease.
Varre JV; Holland WL; Summers SA
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jun; 1867(6):159125. PubMed ID: 35218934
[TBL] [Abstract][Full Text] [Related]
4. Contribution of specific ceramides to obesity-associated metabolic diseases.
Hammerschmidt P; Brüning JC
Cell Mol Life Sci; 2022 Jul; 79(8):395. PubMed ID: 35789435
[TBL] [Abstract][Full Text] [Related]
5. Ceramides and other sphingolipids as drivers of cardiovascular disease.
Choi RH; Tatum SM; Symons JD; Summers SA; Holland WL
Nat Rev Cardiol; 2021 Oct; 18(10):701-711. PubMed ID: 33772258
[TBL] [Abstract][Full Text] [Related]
6. The Lard Works in Mysterious Ways: Ceramides in Nutrition-Linked Chronic Disease.
Nicholson RJ; Norris MK; Poss AM; Holland WL; Summers SA
Annu Rev Nutr; 2022 Aug; 42():115-144. PubMed ID: 35584813
[TBL] [Abstract][Full Text] [Related]
7. Ceramide Metabolism in Cardiovascular Disease: A Network With High Therapeutic Potential.
Zietzer A; Düsing P; Reese L; Nickenig G; Jansen F
Arterioscler Thromb Vasc Biol; 2022 Oct; 42(10):1220-1228. PubMed ID: 36004640
[TBL] [Abstract][Full Text] [Related]
8. Ceramides in Metabolism: Key Lipotoxic Players.
Chaurasia B; Summers SA
Annu Rev Physiol; 2021 Feb; 83():303-330. PubMed ID: 33158378
[TBL] [Abstract][Full Text] [Related]
9. Ceramides: Nutrient Signals that Drive Hepatosteatosis.
Summers SA
J Lipid Atheroscler; 2020 Jan; 9(1):50-65. PubMed ID: 32821721
[TBL] [Abstract][Full Text] [Related]
10. Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification.
Hilvo M; Vasile VC; Donato LJ; Hurme R; Laaksonen R
Front Endocrinol (Lausanne); 2020; 11():570628. PubMed ID: 33133018
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Messengers: ceramides.
Summers SA; Chaurasia B; Holland WL
Nat Metab; 2019 Nov; 1(11):1051-1058. PubMed ID: 32694860
[TBL] [Abstract][Full Text] [Related]
12. Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases.
Raichur S
Front Endocrinol (Lausanne); 2020; 11():483. PubMed ID: 32849276
[TBL] [Abstract][Full Text] [Related]
13. The role of ceramides in metabolic disorders: when size and localization matters.
Turpin-Nolan SM; Brüning JC
Nat Rev Endocrinol; 2020 Apr; 16(4):224-233. PubMed ID: 32060415
[TBL] [Abstract][Full Text] [Related]
14. Ceramides in Adipose Tissue.
Li Y; Talbot CL; Chaurasia B
Front Endocrinol (Lausanne); 2020; 11():407. PubMed ID: 32636806
[TBL] [Abstract][Full Text] [Related]
15. Targeting ceramide metabolism in obesity.
Aburasayn H; Al Batran R; Ussher JR
Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E423-35. PubMed ID: 27382035
[TBL] [Abstract][Full Text] [Related]
16. DES1: A Key Driver of Lipotoxicity in Metabolic Disease.
Blitzer JT; Wang L; Summers SA
DNA Cell Biol; 2020 May; 39(5):733-737. PubMed ID: 32181687
[TBL] [Abstract][Full Text] [Related]
17. Ceramide Metabolism Balance, a Multifaceted Factor in Critical Steps of Breast Cancer Development.
García-González V; Díaz-Villanueva JF; Galindo-Hernández O; Martínez-Navarro I; Hurtado-Ureta G; Pérez-Arias AA
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149660
[TBL] [Abstract][Full Text] [Related]
18. Ceramide on the road to insulin resistance and immunometabolic disorders in transition dairy cows: driver or passenger?
Zhao Y; Zhao H; Li L; Yu S; Liu M; Jiang L
Front Immunol; 2023; 14():1321597. PubMed ID: 38274826
[TBL] [Abstract][Full Text] [Related]
19. Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease.
Nicholson RJ; Pezzolesi MG; Summers SA
Front Endocrinol (Lausanne); 2020; 11():622692. PubMed ID: 33584550
[TBL] [Abstract][Full Text] [Related]
20. Ceramides as modulators of cellular and whole-body metabolism.
Bikman BT; Summers SA
J Clin Invest; 2011 Nov; 121(11):4222-30. PubMed ID: 22045572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
